DENA KAMMAN-RASCHE: Open Payments
NPI 1447735253 · JASPER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 63 payments from 30 companies in 2025. Trend: 2023 $1,165 · 2024 $1,277 · 2025 $1,299
Food & beverage: $1,190Education: $109
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $134 |
| Incyte Corporation | 2 | $121 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| ABBVIE INC. | 4 | $81 |
| Daiichi Sankyo Inc. | 3 | $73 |
| Gilead Sciences, Inc. | 3 | $70 |
| Janssen Biotech, Inc. | 3 | $57 |
| Celgene Corporation | 3 | $55 |
| Geron Corporation | 2 | $47 |
Products named: Trodelvy, TAGRISSO, ELREXFIO, REBLOZYL, DATROWAY, SCEMBLIX, ENHERTU, RYTELO.
Industry payments across IN — which companies pay providers there.
